News Extra [these Stories Appear Only On The Web]

HIV patients benefit from dual drug treatment

BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7309.360/b (Published 18 August 2001) Cite this as: BMJ 2001;323:360
  1. Scott Gottlieb
  1. New York

    Some patients with HIV infection are more likely to benefit from treatment using a combination of two enzyme inhibitors than with either of the drugs on its own, a new study has reported.

    For patients who have failed nucleoside analogue therapy, the protease inhibitor nelfinavir combined with the non-nucleoside reverse transcriptase inhibitor efavirenz is more effective than either of the drugs alone, said a report from Dr Mary Albrecht …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe